Christopher Hong

Dr. Christopher Hong

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2019 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
CHChristopher Hong
Christopher Hong
DDDi Deng
Di Deng
AVAlberto Vera
Alberto Vera
VCVeronica Chiang
Veronica Chiang

1 November 2016 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
CHChristopher Hong
Christopher Hong
EPEric C. Peterson
Eric C. Peterson
DDDale Ding
Dale Ding
SSSamir Sur
Samir Sur
DHDavid Hasan
David Hasan
RSRobert M. Starke
Robert M. Starke

8 August 2020 in Surgical Neurology International
Verified
Journal Article
Open access
CHChristopher Hong
Christopher Hong
AKAdam J. Kundishora
Adam J. Kundishora
Aladine A. ElsamadicyAladine A. Elsamadicy
Aladine A. Elsamadicy
VCVeronica Chiang
Veronica Chiang
Laser interstitial thermal therapy (LITT) is a minimally invasive surgical treatment for multiple intracranial pathologies that are of growing interest to neurosurgeons and their patients and is emerging as an effective alternative to standard of care open surgery in the neurosurgical armamentarium. This option was initially considered for those patients with medical comorbidities and lesion-specific characteristics that confer excessively high risk for resection through a standard craniotomy approach but indications are changing. The PubMed database was searched for studies in the English literature on LITT for the treatment of primary and metastatic brain tumors, meningiomas, as well as for radiation necrosis (RN) in previously irradiated brain tumors. This review provides an update of the relevant literature regarding application of LITT in neurosurgical oncology for the treatment of de novo and recurrent primary gliomas and brain metastases radiographically regrowing after previous irradiation as recurrent tumor or RN. In addition, this review details the limited experience of LITT with meningiomas and symptomatic peritumoral edema after radiosurgery. The advantages and disadvantages, indications, and comparisons to standard of care treatments such as craniotomy for open surgical resection are discussed for each pathology. Finally, the literature on cost-benefit analyses for LITT are reviewed. The studies discussed in this review have helped define the role of LITT in neurosurgical oncology and delineate optimal patient selection and tumor characteristics most suitable to this intervention.

24 February 2022 in Current Oncology
Verified
Journal Article
Open access
PDF file
CHChristopher Hong
Christopher Hong
SOSacit Bulent Omay
Sacit Bulent Omay
Craniopharyngiomas are rare, benign primary brain tumors that arise from remnants of the craniopharyngeal duct epithelium within the sellar and suprasellar region. Despite their benign biology, they may cause significant morbidity, secondary to involvement of nearby eloquent neural structures, such as the pituitary gland, hypothalamus, and optic apparatus. Historically, aggressive surgical resection was the treatment goal to minimize risk of tumor recurrence via open transcranial midline, anterolateral, and lateral approaches, but could lead to clinical sequela of visual, endocrine, and hypothalamic dysfunction. However, recent advances in the endoscopic endonasal approach over the last decade have mostly supplanted transcranial surgery as the optimal surgical approach for these tumors. With viable options for adjuvant radiation therapy, targeted medical treatment, and alternative minimally invasive surgical approaches, the management paradigm for craniopharyngiomas has shifted from aggressive open resection to more minimally invasive but maximally safe resection, emphasizing quality of life issues, particularly in regards to visual, endocrine, and hypothalamic function. This review provides an update on current multi-modal approaches for craniopharyngiomas, highlighting the modern surgical treatment paradigm for this disease entity.

8 March 2022 in World Neurosurgery
Verified
Journal Article
Closed access
AEAladine A. Elsamadicy
Aladine A. Elsamadicy
MSMani Ratnesh S. Sandhu
Mani Ratnesh S. Sandhu
IFIsaac G. Freedman
Isaac G. Freedman
AKAndrew B. Koo
Andrew B. Koo
BRBenjamin C. Reeves
Benjamin C. Reeves
SOSacit Bulent Omay
Sacit Bulent Omay

1 April 2020 in World Neurosurgery
Verified
Journal Article
Closed access
CHChristopher Hong
Christopher Hong
JBJason M. Beckta
Jason M. Beckta
AKAdam J. Kundishora
Adam J. Kundishora
AEAladine A. Elsamadicy
Aladine A. Elsamadicy
VCVeronica Chiang
Veronica Chiang